ALECENSA Drug Use Surveillance

Next Previous
Trial Profile

ALECENSA Drug Use Surveillance

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Sep 2017

At a glance

  • Drugs Alectinib (Primary)
  • Indications Lung cancer
  • Focus Adverse reactions
  • Sponsors Chugai Pharmaceutical

    • Most Recent Events

    • 06 Sep 2017 Status changed from active, no longer recruiting to completed.
    • 01 Jul 2015 Status changed from recruiting to active, no longer recruiting as per University Hospital Medical Information Network - Japan.
    • 10 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top